Bronchiolitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Bronchiolitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Bronchiolitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Severity Score
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bronchiolitis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bronchiolitis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bronchiolitis primary prevention
CDC on Bronchiolitis primary prevention
Bronchiolitis primary prevention in the news
Blogs on Bronchiolitis primary prevention
Directions to Hospitals Treating Bronchiolitis
Risk calculators and risk factors for Bronchiolitis primary prevention

Overview

In general, prevention of bronchiolitis relies on measures to reduce the spread of the viruses that cause respiratory infections (that is, handwashing, and avoiding exposure to those symptomatic with respiratory infections).

Premature infants, and others with certain majory cardiac and respiratory disorders, can receive passive immunization with Palivizumab (a monoclonal antibody against RSV). This form of passive immunization therapy requires monthly injections every winter. Whether it could benefit infants with lung problems secondary to muscular dystrophies and other vulnerable groups is currently unknown.

References

Template:WH Template:WS